Bachem Holding Ag Class B · SIX:BANB
Bachem Holding Ag Class B — Investor Day (2024)
22 slides from Bachem Holding Ag Class B's investor day presentation, 2024
Slide 1: BACHEM
BACHEM
Slide 2: Company Overview
Company Overview About Bachem Vision and Strategy History Sustainability Innovation News & Media News Media Library Events Investor Hub Investor Hub Reports & Presentations Financial Events Careers Peptides Clinical Development Peptide NCE Development Research Custom Synthesis Catalog Peptides Comme
Slide 3: Bubendorf (CH)
Bubendorf (CH)
Slide 4: Vionnaz (CH)
Vionnaz (CH)
Slide 5: Torrance (US)
Torrance (US)
Slide 6: Vista (US)
Vista (US)
Slide 7: St. Helens (UK)
St. Helens (UK)
Slide 8: Sisslerfeld (CH)
Sisslerfeld (CH) Knowledge Hub Contact Peptides Back Clinical Development Peptide NCE Development Research Custom Synthesis Catalog Peptides Commercial Manufacturing Peptide API Amino Acid Derivatives Cosmetic Peptides Peptides for Medical Devices Services & Capabilities Project Management Quality a
Slide 9: Bubendorf (CH)
Bubendorf (CH)
Slide 10: Vionnaz (CH)
Vionnaz (CH)
Slide 11: Torrance (US)
Torrance (US)
Slide 12: Vista (US)
Vista (US)
Slide 13: St. Helens (UK)
St. Helens (UK)
Slide 14: Sisslerfeld (CH)
Sisslerfeld (CH) Knowledge Hub Contact Company Overview Back About Bachem Vision and Strategy History Sustainability Innovation News & Media Back News Media Library Events Investor Hub Back Investor Hub Reports & Presentations Financial Events Careers News News News Filters Category Ad-hoc Company N
Slide 15: Making sustainability measurable and actionable in peptide manufacturing
25 August 2026 Making sustainability measurable and actionable in peptide manufacturing How can we make sustainability measurable and actionable in peptide manufacturing? A year ago, we set out to… Company News
Slide 16: Bachem confirms growth and expects a strong second half 2026
30 July 2026 Bachem confirms growth and expects a strong second half 2026 Ad hoc announcement pursuant to Art. 53 LR of the Swiss stock exchange SIX Ad-hoc Press Release
Slide 17: Bachem plans to build a large-scale production facility in Sisslerfeld
21 July 2026 Bachem plans to build a large-scale production facility in Sisslerfeld Ad hoc announcement pursuant to Art. 53 LR of the Swiss stock exchange SIX Ad-hoc Press Release
Slide 18: Bachem announces changes to the Corporate Executive Committee
05 May 2026 Bachem announces changes to the Corporate Executive Committee Bachem Holding AG (“Bachem”, SIX: BANB) today announced that Torsten Wöhr, Chief Commercial Officer, has decided to pursue… Company News Press Release
Slide 19: Bachem Annual General Meeting 2026
29 April 2026 Bachem Annual General Meeting 2026 All proposals of the Board of Directors approved. Dividend of CHF 0.90 per share. Bachem Holding AG (“Bachem”,… Company News Press Release
Slide 20: Bachem secures financing of strategic growth initiatives
27 April 2026 Bachem secures financing of strategic growth initiatives Bachem Holding AG (“Bachem”, SIX: BANB) announced today the closing of a revolving credit facility of CHF 500… Company News Press Release Load more articles Media Contact
Slide 21: Patrick Barth
Patrick Barth Head Group Communications get in touch get in touch
Slide 22: Development and manufacture of peptides and oligonucleotides for over 50 years
Development and manufacture of peptides and oligonucleotides for over 50 years. Looking for more information? Webinars News Clinical development for Peptide NCEs Events Peptide Calculator Sustainability Contact Us General Conditions Legal Statement Privacy Policy Imprint © 2026 Bachem Inc. All right